- Home
- PMN vs CRIS Comparison
PMN vs CRIS Comparison
Compare PMN & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMN
- CRIS
- Stock Information
- Founded
- PMN 2004
- CRIS 2000
- Country
- PMN Canada
- CRIS United States
- Employees
- PMN N/A
- CRIS N/A
- Industry
- PMN Pharmaceuticals and Biotechnology
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PMN Health Care
- CRIS Health Care
- Exchange
- PMN Nasdaq
- CRIS Nasdaq
- Market Cap
- PMN 23.5M
- CRIS 22.9M
- IPO Year
- PMN N/A
- CRIS 2000
- Fundamental
- Price
- PMN $0.42
- CRIS $1.49
- Analyst Decision
- PMN Strong Buy
- CRIS Strong Buy
- Analyst Count
- PMN 3
- CRIS 2
- Target Price
- PMN $4.33
- CRIS $16.50
- AVG Volume (30 Days)
- PMN 780.8K
- CRIS 77.0K
- Earning Date
- PMN 11-14-2025
- CRIS 11-06-2025
- Dividend Yield
- PMN N/A
- CRIS N/A
- EPS Growth
- PMN N/A
- CRIS N/A
- EPS
- PMN N/A
- CRIS N/A
- Revenue
- PMN N/A
- CRIS $11,405,000.00
- Revenue This Year
- PMN N/A
- CRIS $2.72
- Revenue Next Year
- PMN N/A
- CRIS $8.27
- P/E Ratio
- PMN N/A
- CRIS N/A
- Revenue Growth
- PMN N/A
- CRIS 12.24
- 52 Week Low
- PMN $0.38
- CRIS $1.02
- 52 Week High
- PMN $1.59
- CRIS $5.00
- Technical
- Relative Strength Index (RSI)
- PMN 41.97
- CRIS 40.22
- Support Level
- PMN $0.41
- CRIS $1.49
- Resistance Level
- PMN $0.48
- CRIS $1.68
- Average True Range (ATR)
- PMN 0.04
- CRIS 0.09
- MACD
- PMN -0.00
- CRIS -0.00
- Stochastic Oscillator
- PMN 7.70
- CRIS 19.83
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.